{"nctId":"NCT00257660","briefTitle":"Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia","startDateStruct":{"date":"2005-10-10","type":"ACTUAL"},"conditions":["Cervical Dystonia"],"count":116,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Biological: Botulinum toxin type A"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (Dysport®)"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Cervical dystonia with at least 18 months since onset, and previously untreated with botulinum toxin or previously treated with botulinum toxin type A or B with a minimum interval of 16 weeks since the last injection and having returned at least to their usual pre-treatment status\n* TWSTRS severity, disability and total scores meeting the defined criteria at baseline\n\nExclusion Criteria:\n\n* Pure anterocollis or pure retrocollis\n* In apparent remission from cervical dystonia\n* Previous poor response to the last two botulinum toxin type A or type B treatments\n* Being treated with type B toxin due to lack of efficacy to type A toxin or have known neutralizing antibodies to type A toxin","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)","description":"TWSTRS is comprised of three different components which are severity, disability \\& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.99","spread":"12.33"},{"groupId":"OG001","value":"-5.23","spread":"9.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.83","spread":"7.97"},{"groupId":"OG001","value":"45.81","spread":"8.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.04","spread":"12.65"},{"groupId":"OG001","value":"40.22","spread":"11.75"}]}]}]},{"type":"SECONDARY","title":"Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)","description":"TWSTRS is comprised of three different components which are severity, disability \\& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.82","spread":"11.53"},{"groupId":"OG001","value":"-5.59","spread":"11.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.83","spread":"7.97"},{"groupId":"OG001","value":"45.81","spread":"8.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.31","spread":"10.99"},{"groupId":"OG001","value":"39.64","spread":"13.50"}]}]}]},{"type":"SECONDARY","title":"Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) Total Score","description":"TWSTRS is comprised of three different components which are severity, disability \\& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.98","spread":"11.12"},{"groupId":"OG001","value":"-4.53","spread":"7.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.83","spread":"7.97"},{"groupId":"OG001","value":"45.81","spread":"8.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.04","spread":"11.76"},{"groupId":"OG001","value":"40.76","spread":"11.08"}]}]}]},{"type":"SECONDARY","title":"Subject Visual Analogue Score (VAS) for Cervical Dystonia (CD) Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.2","spread":"29.5"},{"groupId":"OG001","value":"-6.7","spread":"20.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.7","spread":"19.7"},{"groupId":"OG001","value":"63.6","spread":"18.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.3","spread":"24.4"},{"groupId":"OG001","value":"55.7","spread":"20.6"}]}]}]},{"type":"SECONDARY","title":"Investigator VAS for CD Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-23.1","spread":"22.1"},{"groupId":"OG001","value":"-9.1","spread":"20.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.3","spread":"15.8"},{"groupId":"OG001","value":"65.3","spread":"18.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3","spread":"21.7"},{"groupId":"OG001","value":"56.8","spread":"21.8"}]}]}]},{"type":"SECONDARY","title":"Subject VAS for CD Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.6","spread":"30.0"},{"groupId":"OG001","value":"-5.4","spread":"25.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.7","spread":"19.7"},{"groupId":"OG001","value":"63.6","spread":"18.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.7","spread":"24.9"},{"groupId":"OG001","value":"57.8","spread":"27.5"}]}]}]},{"type":"SECONDARY","title":"Investigator's VAS for CD Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.5","spread":"22.7"},{"groupId":"OG001","value":"-5.0","spread":"21.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.3","spread":"15.8"},{"groupId":"OG001","value":"65.3","spread":"18.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.8","spread":"22.3"},{"groupId":"OG001","value":"60.8","spread":"24.6"}]}]}]},{"type":"SECONDARY","title":"Subject VAS for CD Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.4","spread":"25.2"},{"groupId":"OG001","value":"-4.6","spread":"23.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.7","spread":"19.7"},{"groupId":"OG001","value":"63.6","spread":"18.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55.4","spread":"25.5"},{"groupId":"OG001","value":"58.2","spread":"25.7"}]}]}]},{"type":"SECONDARY","title":"Investigator's VAS for CD Symptom Assessment","description":"The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms) to 100 mm (worst possible symptoms).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.5","spread":"18.9"},{"groupId":"OG001","value":"-5.8","spread":"15.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.3","spread":"15.8"},{"groupId":"OG001","value":"65.3","spread":"18.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.8","spread":"20.8"},{"groupId":"OG001","value":"60.0","spread":"21.5"}]}]}]},{"type":"SECONDARY","title":"SF-36 Mental Health Summary Score","description":"SF-36 is a Quality of Life scale comprising eight individual domains. The QoL score for each domain is on a scale from 0 (worst health possible) to 100 (best health possible). SF-36 Mental Health Summary Score is derived from four individual domains (vitality, social functioning, role limitations due to emotional problems and mental health).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.11","spread":"9.18"},{"groupId":"OG001","value":"2.48","spread":"8.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.52","spread":"10.41"},{"groupId":"OG001","value":"43.31","spread":"11.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.00","spread":"8.69"},{"groupId":"OG001","value":"43.41","spread":"12.30"}]}]}]},{"type":"SECONDARY","title":"SF-36 Physical Health Summary Score","description":"SF-36 is a Quality of Life scale comprising eight individual domains. The QoL score for each domain is on a scale from 0 (worst health possible) to 100 (best health possible). SF-36 Physical Health Summary Score is derived from four individual domains (physical functioning, role physical, bodily pain and general health).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.37","spread":"5.46"},{"groupId":"OG001","value":"-0.64","spread":"6.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.42","spread":"8.84"},{"groupId":"OG001","value":"43.18","spread":"7.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.70","spread":"8.76"},{"groupId":"OG001","value":"42.49","spread":"8.84"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Considered by the Investigator to be Overall Treatment Successes","description":"The number of participants considered to be overall treatment successes by the investigator at week 12 was assessed.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":55},"commonTop":["Neck pain","Dysphagia","Injection site pain"]}}}